Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Ni Zhao, Bin Di, Lili Xu
Cytokine & Growth Factor Reviews (2021) Vol. 61, pp. 2-15
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation
Jingwen Liu, Jing Zhou, Yuling Luan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 99
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
Mojtaba Shohan, Roohangiz Nashibi, Mohammad‐Reza Mahmoudian‐Sani, et al.
European Journal of Pharmacology (2021) Vol. 914, pp. 174615-174615
Open Access | Times Cited: 86
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
Shilei Zhang, Lulan Wang, Genhong Cheng
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1869-1884
Open Access | Times Cited: 58
MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes
Saba Bakhshi, Saeedeh Shamsi
International Immunopharmacology (2022) Vol. 106, pp. 108595-108595
Closed Access | Times Cited: 50
The IL-1 cytokine family as custodians of barrier immunity
Laura Matarazzo, Yasmina Hernandez-Santana, Patrick Walsh, et al.
Cytokine (2022) Vol. 154, pp. 155890-155890
Open Access | Times Cited: 43
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways
Michaël Maes, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10362-10362
Open Access | Times Cited: 40
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37
Chronic Fatigue, Depression and Anxiety Symptoms in Long COVID Are Strongly Predicted by Neuroimmune and Neuro-Oxidative Pathways Which Are Caused by the Inflammation during Acute Infection
Hussein Kadhem Al‐Hakeim, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 511-511
Open Access | Times Cited: 37
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
Na Li, Ruijia Zhang, Minghai Tang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14447-14473
Closed Access | Times Cited: 35
Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
Claudio Tirelli, Mara De Amici, Cristina Albrici, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 177-177
Open Access | Times Cited: 28
Role of Endothelium in Cardiovascular Sequelae of Long COVID
L. Santoro, Vincenzo Zaccone, Lorenzo Falsetti, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2239-2239
Open Access | Times Cited: 21
Regulation and functions of the NLRP3 inflammasome in RNA virus infection
Zhaoyang Yue, Xuelong Zhang, Yu Gu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 11
The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD
Feng-xin Chu, Xiao Wang, Bo Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 2, pp. 227-242
Closed Access | Times Cited: 9
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment
Richard Head, Eugenie R. Lumbers, Bevyn Jarrott, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 34
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Jiaying Shen, Junyan Fan, Yue Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation
Ahmed Eltayeb, Faisal Al‐Sarraj, Mona G. Alharbi, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 3
Closed Access | Times Cited: 6
Advancements in research on the immune-inflammatory mechanisms mediated by NLRP3 inflammasome in ischemic stroke and the regulatory role of natural plant products
Kailin Yang, Liuting Zeng, Qi He, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1
Chuda Chittasupho, Sonthaya Umsumarng, Kamonwan Srisawad, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 751-751
Open Access | Times Cited: 6
Effect of increasing doses of colchicine on the treatment of 333 COVID‐19 inpatients
Rumen Tiholov, A Lilov, Gergana Georgieva, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 5
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 5
Processing of Genomic RNAs by Dicer in Bat Cells Limits SARS-CoV-2 Replication
Iyanuoluwani Owolabi, Shazeed-UI Karim, Sweta Khanal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Analysis of the immune response in COVID-19
Altijana Hromić‐Jahjefendić, Alaa A. A. Aljabali
Progress in molecular biology and translational science (2025)
Closed Access
Page 1 - Next Page

Scroll to top